Radiological and Surgical Analysis of Frontal Recess Variations in Endoscopic Sinus Surgery (NCT07748806) | Clinical Trial Compass
CompletedNot Applicable
Radiological and Surgical Analysis of Frontal Recess Variations in Endoscopic Sinus Surgery
Egypt40 participantsStarted 2025-09-01
Plain-language summary
Introduction
The frontal recess is a narrow and anatomically variable region that forms the frontal sinus drainage pathway. Variations in its anatomy, particularly those related to the agger nasi cell and other frontal recess cells, can impair frontal sinus drainage and contribute to the development of frontal sinus disease. High-resolution computed tomography and endoscopic evaluation are essential for identifying these variations and planning endoscopic sinus surgery. A thorough understanding of frontal recess anatomy is crucial for achieving adequate frontal sinus drainage, improving surgical outcomes, and minimizing complications due to the close proximity of the orbit and skull base.
The Study aim to evaluate the anatomical variations of the frontal recess using radiological and surgical assessment and determine their significance in the management of frontal sinus disorders during endoscopic sinus surgery.
Who can participate
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age : (20 -60 years old ).
* Sex: both males and females.
* Patients were selected from the otorhinolaryngology outpatient clinic of Al-Azhar University Hospital in Assiut in a consecutive manner.
* All patients were generally well and fit for surgery.
Exclusion Criteria:
* Patients with massive inflammatory disease of specific in
* infections (e.g., rhinoscleroma).
* Malignancy.
* Severe nasal trauma.
* Foreign body.
* Previous nasal surgery.
* Atrophic diseases or systemic diseases and patients not fit for surgery.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.